Bangalore headquartered biopharmaceutical company, Biocon Ltd., announced that its step-down, wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, effective 1st September, 2023. The facility was acquired for a total consideration $7.7 million. As part of the acquisition, the...